Key Marketed Proprietary Products > ENJUVIA™

Duramed's ENJUVIA™ is an FDA-approved, once-daily oral estrogen therapy for the treatment of moderate-to-severe vasomotor symptoms and the treatment of moderate to severe vaginal dryness and pain with intercourse, symptoms of vulvar vaginal atrophy, associated with menopause. A plant-derived formulation, ENJUVIA™ contains a blend of 10 synthetic estrogenic substances, including Delta 8,9 dehydroesterone sulfate (DHES). ENJUVIA™ tablets are available in a variety of dosage strengths including 0.3 mg, 0.45 mg, 0.625 mg, 0.9 mg and 1.25 mg. ENJUVIA™ uses a unique delivery system, consisting of Surelease® technology with a cellulose-based polymer tablet design, and provides slow release of estrogens over several hours.

The Company details ENJUVIA™ to physicians in the United States using its Duramed Women's Healthcare and Institutional Sales Forces. Marketing support includes professional-targeted materials, published data from our clinical studies demonstrating the efficacy and safety of ENJUVIA®, and valuable patient information. The Company further complements its promotional efforts with a professional advertising program in leading medical journals, attendance at medical meetings and educational brochures for patients.

Important Information About Estrogen Use

Estrogens increase the risk for cancer of the uterus (womb). If you experience persistent or recurring vaginal bleeding while taking estrogens, let your doctor know right away, as this could be a warning sign for cancer. Your doctor should check for the cause of any unusual vaginal bleeding after menopause. Estrogens (alone or in combination with progestins) should not be used to prevent heart disease, heart attacks, strokes or dementia.

Estrogens (alone or in combination with progestins) may increase the risk of heart attack, stroke, breast cancer and blood clots. Estrogens with progestins may increase your risk of dementia. Because of these risks, estrogens should be used at the lowest dose possible for the shortest time possible. You and your doctor should talk regularly to determine whether you still need treatment with ENJUVIA™.

Please see complete prescribing information at www.ENJUVIA.com

Click HERE to download Patient Information Brochure.

Click HERE to be taken to the product guide website.